Advertisement
Advertisement

More Related Content

Viewers also liked(20)

Advertisement
Advertisement

Pharma new bus model St Petersburg Russia

  1. Pharma's new business model: consumer centric approaches to increase ROI Health Business Consult Innovating the way we care
  2. Assistant  professor  of  professional  development Consultant  pharma  >25  yrs Trainer  of  HC  specialists  &  doctors Chairman ISATT Development  Retail   formula  pharmacists Strategic  advisor Social  media #hcsmeu   Classic  Music Health  care   technology Ehealth  -­‐  Telecare Chronic  diseases   challenge Drums  &  Trombone Disc  jockey Drimpy  ParIcipatory   HC  PlaJorm Rob Halkes @rohal The  FOX  group  LLC US Pharma  commercial development
  3. On fundamentals of Protection of Public Health Russian Federation, Jan. 1st 2012. .. A new system of accountable officials and .. responsibility of healthcare budget holders Rules of interaction between the pharmaceutical industry and physicians Standards of providing medical and drug aid Regional structure under which high cost nosologies will be purchased and supervised by regions Cegedim white paper april, 2012
  4. CEO Panel at Russian Pharmaceutical Forum 2012
  5. CEO Panel at Russian Pharmaceutical Forum 2012 • Uncertainty / Stability ? / Predictability? • Goals of the Government? • Access for patients to medicines? • Reimbursement? • Local market conditions?
  6. What makes your influence as a pharma company?
  7. What makes your influence as a pharma company? “ What you actually DO in the local market will make that your voice can be heard...
  8. What makes your influence as a pharma company? “ What you actually DO in the local market will make that your voice can be heard... ...It makes the difference between being seen as ‘helping’ instead of ‘exploiting’”
  9. Elections to Russian State Duma Modernization program - the stage of active development of the budget Presidential Election Year of treatment standards Regional modeling of drug compensation programs Preparing of patient registries Slow down of concentration process in distribution chain First innovation products of Russian Pharma companies The beginning of activity of self- regulatory organizations Licensing of healthcare professionals Start the process of consolidation of regional programs reimbursement Launch of reimbursement pilot program in regions Launch of reimbursement program in regions The mass privatization of HCP Bln $ 25 Bln $75 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Figure 1: Long Term Development Scenario of Russia Pharmaceutical industry Source: Cegedim aggregated opinion from industry experts: government employees, industry leaders, anlaysts
  10. May 2013: “- -” and “++” to pharma?
  11. • Healthcare, life expectancy Russia not in good shape • Is there enough budget? (Popovich) • No reimbursement • Uncertainty of policy and regulations • Procurement issues • “Interchangeability” • No data • Formal - Informal • Many different (competing) players in the channel • Advertising rules are not clear • Russia too big for “big pharma?” May 2013: “- -” and “++” to pharma?
  12. • Healthcare, life expectancy Russia not in good shape • Is there enough budget? (Popovich) • No reimbursement • Uncertainty of policy and regulations • Procurement issues • “Interchangeability” • No data • Formal - Informal • Many different (competing) players in the channel • Advertising rules are not clear • Russia too big for “big pharma?” • Healthcare, life expectancy Russia not in good shape • PharmaMed 2020 • Roadmap for health care • Market is still growing (12%) • Middle class is growing • Collaboration with authorities, national, regional, local (physician committees) • Patients’ access to medicine • Standards of medical treatment • Not so much cooperation between protagonists in care.. May 2013: “- -” and “++” to pharma?
  13. NL as compared with Russia
  14. NL as compared with Russia
  15. 2006 - Liberalisation of HC market: • Health Care Insurance (HCI) for everyone - obliged; • HCI companies have: - Power of selection of care providers - Buying power: pharma tenders, to their patients, - Policy towards integrated, chronic care -> initiated cooperations of care providers in health care groups for family care • Regional / Local Rx decisions by local protocol committees NL as compared with Russia
  16. 2006 - Liberalisation of HC market: • Health Care Insurance (HCI) for everyone - obliged; • HCI companies have: - Power of selection of care providers - Buying power: pharma tenders, to their patients, - Policy towards integrated, chronic care -> initiated cooperations of care providers in health care groups for family care • Regional / Local Rx decisions by local protocol committees NL as compared with Russia
  17. 1.6 Prijsontwikkeling receptgeneesmiddelen op basis van SFK prijsindex (januari 1996=100), afzet gewogen gemiddelde) Bron: Stichting Farmaceutische Kengetallen 100% Invoering Wet Geneesmiddelenprijzen Invoering claw back Start convenantsperiode Introductie vrije prijzen Transitieakkoord Tijdelijke invoering maatregel “De Geus” (Individueel) Preferentiebeleid Verhoging claw back Akkoord VWS - KNMP 90% 80% 70% 60% 40% 50% 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 //
  18. 1.6 Prijsontwikkeling receptgeneesmiddelen op basis van SFK prijsindex (januari 1996=100), afzet gewogen gemiddelde) Bron: Stichting Farmaceutische Kengetallen 100% Invoering Wet Geneesmiddelenprijzen Invoering claw back Start convenantsperiode Introductie vrije prijzen Transitieakkoord Tijdelijke invoering maatregel “De Geus” (Individueel) Preferentiebeleid Verhoging claw back Akkoord VWS - KNMP 90% 80% 70% 60% 40% 50% 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 // • Diminishing access to prescribers: about 50% in 2006; • Growing influence of new stakeholders Rx: health care insurance companies, local protocol committees, • Growing pressure to prescribe generics, • More Regulation of Pharma promotion, by the government, • Deteriorating image of the pharmaceutical industry in general, • Growing Costs of health care on national political agenda • Slower registration and decisions about reimbursement
  19. The Dutch Case
  20. The Dutch Case If pharma wants to distinguish itself, it needs to show first that it understands the way their direct (Rx)customers, health care providers are to develop!
  21. The Dutch Case If pharma wants to distinguish itself, it needs to show first that it understands the way their direct (Rx)customers, health care providers are to develop!
  22. The Dutch Case ....is all about “being there, locally” to demonstrate that pharma does understand and can make the difference to situations! If pharma wants to distinguish itself, it needs to show first that it understands the way their direct (Rx)customers, health care providers are to develop!
  23. Key Customer Focus
  24. Key Customer Focus A new commercial Approach for Pharma Putting (the right) customers first
  25. Key Customer Focus A new commercial Approach for Pharma Putting (the right) customers first ☑  Focused Development
  26. Key Customer Focus A new commercial Approach for Pharma Putting (the right) customers first ☑  Focused Development ☑ Customer Centric
  27. Key Customer Focus A new commercial Approach for Pharma Putting (the right) customers first ☑  Focused Development ☑ Customer Centric ☑ Value Innovation in Proposition
  28. Key Customer Focus A new commercial Approach for Pharma Putting (the right) customers first ☑  Focused Development ☑ Customer Centric ☑ Value Innovation in Proposition ☑  New ways to co-operate to better care
  29. Key Customer Focus A new commercial Approach for Pharma Putting (the right) customers first ☑  Focused Development ☑ Customer Centric ☑ Value Innovation in Proposition ☑  New ways to co-operate to better care ☑  Integrating classic, Sales Marketing and Medical
  30. Key Customer Focus A new commercial Approach for Pharma Putting (the right) customers first ☑  Focused Development ☑ Customer Centric ☑ Value Innovation in Proposition ☑  New ways to co-operate to better care ☑  Integrating classic, Sales Marketing and Medical ☑  Integrated Business Cycles
  31. Key Customer Focus A new commercial Approach for Pharma Putting (the right) customers first ☑  Focused Development ☑ Customer Centric ☑ Value Innovation in Proposition ☑  New ways to co-operate to better care ☑  Integrating classic, Sales Marketing and Medical ☑  Integrated Business Cycles Effective adaptation to different market conditions
  32. Focus And Collaboration Customer Centric
  33. Focus And Collaboration • Think Customer Centric
  34. Focus And Collaboration • Think • What is going on Customer Centric
  35. Focus And Collaboration • Think • What is going on • With what can you help to create better care Customer Centric
  36. Focus And Collaboration • Think • What is going on • With what can you help to create better care • Pull resources together Customer Centric
  37. Focus And Collaboration • Think • What is going on • With what can you help to create better care • What customers - how to select • Pull resources together Customer Centric
  38. Focus And Collaboration • Think • What is going on • With what can you help to create better care • What customers - how to select • Take the journey step by step • Pull resources together Customer Centric
  39. Focus And Collaboration • Think • What is going on • With what can you help to create better care • What customers - how to select • Take the journey step by step • Pull resources together • Act Customer Centric
  40. Focus And Collaboration • Think • What is going on • With what can you help to create better care • What customers - how to select • Take the journey step by step • Pull resources together • Act • Market intelligence • Added value • Align and Integrate internal silo’s •Segmentation Targeting • Tactics and operations • Develop partnership Customer Centric
  41. Strategic Starting Points
  42. Strategic Starting Points Commodity Trap
  43. Strategic Starting Points Commodity Trap AddValue
  44. Strategic Starting Points Commodity Trap Low cost position AddedValue position Prices Market Top Value AddValue
  45. AddValue
  46. AddValue The general principle for business growth works the same for pharmaceutical marketing Commodities Specialties Services Experiences Competition Clients’needs Differentiated Prices Alike Market Top Value Desired Not relevant
  47. AddValue
  48. AddValue Create an integrated offering From Product to Care
  49. AddValue Create an integrated offering From Product to Care Product Core 1st layer therapy 2nd layer therapy
  50. AddValue Create an integrated offering From Product to Care Rx Drug profile Pharmaceutical and pharma economically Product Core 1st layer therapy 2nd layer therapy Product Information on Characteristics, features, functionality and effects
  51. AddValue Create an integrated offering From Product to Care Rx Focus on adequate use for the individual patient in the right condition Drug profile Pharmaceutical and pharma economically Product Core 1st layer therapy 2nd layer therapy Product Information on Characteristics, features, functionality and effects Augmented brand Support, service by marketing tools through different channels
  52. AddValue Create an integrated offering From Product to Care Rx A. Professional Support from HC professionals and others for the patient B. Cooperation and synergy between co-acting care providers Focus on adequate use for the individual patient in the right condition Drug profile Pharmaceutical and pharma economically Product Core 1st layer therapy 2nd layer therapy Product Information on Characteristics, features, functionality and effects Augmented brand Support, service by marketing tools through different channels Value proposition A. Patient oriented health care activities by Health Care Professionals B. Increasing HC effects by improvement of care and health processes
  53. The Chalkboard Sketch of A new Commercial Market Approach Basic Considerations. What market conditions, what tools, what applications?
  54. Tools specifically: Access and Added Value Profiling, segmentation, targeting Sales teams Multidisciplinary accountplan design Edetailing multi channel social media Partnership development The Chalkboard Sketch of A new Commercial Market Approach Basic Considerations. What market conditions, what tools, what applications?
  55. The new CommercialCycle of Pharma Chalkboard Sketch Health Business Consult Innovating the way we care
  56. The new CommercialCycle of Pharma Chalkboard Sketch Market Conditions Health Business Consult Innovating the way we care
  57. The new CommercialCycle of Pharma Chalkboard Sketch Market Conditions RX Accounts Health Business Consult Innovating the way we care
  58. Market Conditions RX Accounts Health Business Consult Innovating the way we care
  59. Market Conditions RX Accounts Health Business Consult Innovating the way we care
  60. Market Conditions RX Accounts Health Business Consult Innovating the way we care Individual Rx Physicians
  61. Market Conditions RX Accounts Health Business Consult Innovating the way we care Individual Rx Physicians
  62. Market Conditions RX Accounts Health Business Consult Innovating the way we care Individual Rx Physicians Promotion
  63. Market Conditions RX Accounts Individual Rx Physicians Promotion
  64. Market Conditions RX Accounts Individual Rx Physicians Promotion #Costs of market Approach ?
  65. Market Conditions RX Accounts Individual Rx Physicians Promotion #Costs of market Approach ?☹ UP - If not focused enough
  66. Market Conditions RX Accounts Individual Rx Physicians Promotion #Costs of market Approach ?☹ UP - If not focused enough Down! If Focused rightly ☺
  67. Market Conditions RX Accounts Individual Rx Physicians Promotion #Costs of market Approach ?☹ UP - If not focused enough Down! If Focused rightly ☺
  68. Market Conditions Individual Rx Physicians Promotion #Costs of market Approach ?☹ UP - If not focused enough Down! If Focused rightly ☺
  69. Market Conditions Individual Rx Physicians Promotion #Costs of market Approach ?☹ UP - If not focused enough Down! If Focused rightly ☺ RX decision Accounts
  70. Market Conditions Individual Rx Physicians Promotion #Costs of market Approach ?☹ UP - If not focused enough Down! If Focused rightly ☺ RX decision Accounts
  71. Market Conditions Individual Rx Physicians Promotion #Costs of market Approach ?☹ UP - If not focused enough Down! If Focused rightly ☺ RX decision Accounts Differentiate From Standard Individual Promotion To Key Customer Focus!!!
  72. Market Conditions Differentiate approaches To Key Customer Focus ! Individual Rx promotion KEY Accounts •Fulfillment • Evaluating •Planning • Selecting • Managing
  73. Market Conditions Differentiate approaches To Key Customer Focus ! Individual Rx promotion KEY Accounts Make Focus your main stream Business APproach •Fulfillment • Evaluating •Planning • Selecting • Managing
  74. Market Conditions Differentiate approaches To Key Customer Focus ! Individual Rx promotion KEY Accounts ? What are the Points of intervention to create focus Make Focus your main stream Business APproach •Fulfillment • Evaluating •Planning • Selecting • Managing
  75. • Market Conditions Differentiate To Key Customer Focus Individual Rx promotion • What are the points of INtervention to create Focus ? KEy Accounts • Care & Therapy Conditions • Rx Conditions • Account Conditions • Patients’ Conditions
  76. •Individual Rx promotion • Market Conditions • Care & Therapy Conditions •RxConditions • Account Conditions • Patients’ Conditions Key Focus Accounts What tools to use?
  77. •Individual Rx promotion ROS • Market Conditions • Care & Therapy Conditions •RxConditions • Account Conditions • Patients’ Conditions Key Focus Accounts What tools to use?
  78. •Individual Rx promotion ROI ROS • Market Conditions • Care & Therapy Conditions •RxConditions • Account Conditions • Patients’ Conditions Key Focus Accounts What tools to use? ₷ $ € £ ¢ ¥
  79. •Individual Rx promotion • Market Access •Account profiling •Segmentation & targeting For quantity & quality! • Mutlidisciplinairy Design of Account PLans! • Account specific development of partnership! ROI ROS • Market Conditions • Care & Therapy Conditions •RxConditions • Account Conditions • Patients’ Conditions Key Focus Accounts • KAM, CRM and cLosed loop marketing • Multi channel management •Care Support Services •Social Media •Social Media •Ehealth What tools to use? ₷ $ € £ ¢ ¥ •eDetailing • Standards of treatment
  80. •Market Conditions KEy Customers • Care & Therapy Conditions •Rx Conditions • Account Conditions •Patients’ Conditions
  81. •Market Conditions KEy Customers • Care & Therapy Conditions •Rx Conditions • Account Conditions •Patients’ Conditions • Market Access
  82. •Market Conditions KEy Customers • Care & Therapy Conditions •Rx Conditions • Account Conditions •Patients’ Conditions • Market Access & added value
  83. We need a Market Approach
  84. We need a Market Approach .. that selects , focuses and builds on the right customers
  85. We need a Market Approach .. that selects , focuses and builds on the right customers 1 System of Market Access : Keyword: Localizing to local Rx committees “Guided Navigation”
  86. We need a Market Approach .. that selects , focuses and builds on the right customers 2 Segmentation and Targeting on both Potential and Quality Characteristics 1 System of Market Access : Keyword: Localizing to local Rx committees “Guided Navigation”
  87. We need a Market Approach .. that selects , focuses and builds on the right customers 3 System of promotion 2 Segmentation and Targeting on both Potential and Quality Characteristics 1 System of Market Access : Keyword: Localizing to local Rx committees “Guided Navigation”
  88. We need a Market Approach .. that selects , focuses and builds on the right customers 3 System of promotion - edetailing/online/social media - multichannel management 2 Segmentation and Targeting on both Potential and Quality Characteristics 1 System of Market Access : Keyword: Localizing to local Rx committees “Guided Navigation”
  89. We need a Market Approach .. that selects , focuses and builds on the right customers 3 System of promotion - edetailing/online/social media - multichannel management - multidisciplinary accountdesign 2 Segmentation and Targeting on both Potential and Quality Characteristics 1 System of Market Access : Keyword: Localizing to local Rx committees “Guided Navigation”
  90. We need a Market Approach .. that selects , focuses and builds on the right customers 3 System of promotion - edetailing/online/social media - multichannel management - multidisciplinary accountdesign - tailormade propositions 2 Segmentation and Targeting on both Potential and Quality Characteristics 1 System of Market Access : Keyword: Localizing to local Rx committees “Guided Navigation”
  91. We need a Market Approach .. that selects , focuses and builds on the right customers 3 System of promotion - edetailing/online/social media - multichannel management - multidisciplinary accountdesign - tailormade propositions 4 Development of Partnership 2 Segmentation and Targeting on both Potential and Quality Characteristics 1 System of Market Access : Keyword: Localizing to local Rx committees “Guided Navigation”
  92. We need a Market Approach .. that selects , focuses and builds on the right customers 3 System of promotion - edetailing/online/social media - multichannel management - multidisciplinary accountdesign - tailormade propositions 4 Development of Partnership From promotion via collaboration to cocreation 2 Segmentation and Targeting on both Potential and Quality Characteristics 1 System of Market Access : Keyword: Localizing to local Rx committees “Guided Navigation”
  93. We need a Market Approach .. that selects , focuses and builds on the right customers 3 System of promotion - edetailing/online/social media - multichannel management - multidisciplinary accountdesign - tailormade propositions 4 Development of Partnership From promotion via collaboration to cocreation 2 Segmentation and Targeting on both Potential and Quality Characteristics 1 System of Market Access : Keyword: Localizing to local Rx committees “Guided Navigation” 5 Integrated Care Support
  94. We need a Market Approach .. that selects , focuses and builds on the right customers 3 System of promotion - edetailing/online/social media - multichannel management - multidisciplinary accountdesign - tailormade propositions 4 Development of Partnership From promotion via collaboration to cocreation 2 Segmentation and Targeting on both Potential and Quality Characteristics 1 System of Market Access : Keyword: Localizing to local Rx committees “Guided Navigation” 5 Integrated Care Support Account- Marketing en Medical management
  95. .. that creates results just like these:
  96. We need a Market Approach .. that selects , focuses and builds on the right customers
  97. We need a Market Approach .. that selects , focuses and builds on the right customers Some Examples: Market Access Detail e- Detail Promote & Engage Connect & Interact Develop & Create Co-Create Co-Operate Segmentation Targeting Promotion Partnership
  98. Market Access
  99. Market Access - National & Regional & Local - Not just launch and registration - KOL - DMU ~ (in)formal - Committee’s (EDL - Standards) - Status Quo of Care - Profiles of markets - Org/Inst/DMU/Care Providers
  100. Market Access - National & Regional & Local - Not just launch and registration - KOL - DMU ~ (in)formal - Committee’s (EDL - Standards) - Status Quo of Care - Profiles of markets - Org/Inst/DMU/Care Providers ❍ MA = Pharma & Health Economy ≠ Promotion
  101. Market Access - National & Regional & Local - Not just launch and registration - KOL - DMU ~ (in)formal - Committee’s (EDL - Standards) - Status Quo of Care - Profiles of markets - Org/Inst/DMU/Care Providers ❍ Education and communications characteristics ❍ MA = Pharma & Health Economy ≠ Promotion
  102. Market Access - National & Regional & Local - Not just launch and registration - KOL - DMU ~ (in)formal - Committee’s (EDL - Standards) - Status Quo of Care - Profiles of markets - Org/Inst/DMU/Care Providers ❍ Added value Depending upon stage of development process ❍ Education and communications characteristics ❍ MA = Pharma & Health Economy ≠ Promotion
  103. Market Access
  104. Market Access Internal Department“Heath Care Affairs” Working with marketing and Medical/KOL- mngmnt
  105. Market Access Stimulating developments in the market Depending on stage of process: Internal Department“Heath Care Affairs” Working with marketing and Medical/KOL- mngmnt
  106. Market Access Stimulating developments in the market Depending on stage of process: Internal Department“Heath Care Affairs” Working with marketing and Medical/KOL- mngmnt ❍ Building relationship between Physicians & Pharmacists
  107. Market Access Stimulating developments in the market Depending on stage of process: Internal Department“Heath Care Affairs” Working with marketing and Medical/KOL- mngmnt ❍ E.g.: innovation fund for local care providers ❍ Building relationship between Physicians & Pharmacists
  108. Rx Accounts Segmentation -Targeting
  109. Rx Accounts Segmentation -Targeting
  110. Individuals Networks AccountsDMU’s Rx Accounts Segmentation -Targeting
  111. Individuals Networks AccountsDMU’s Not just individuals, but their networks too, their accessibility and feasibility for success to You! Rx Accounts Segmentation -Targeting
  112. “You don’t want to spend time and money in a lost case”
  113. Profile and Classify “You don’t want to spend time and money in a lost case” Profile and Classify
  114. Profile and Classify “You don’t want to spend time and money in a lost case”
  115. Profile and Classify Potential: • Estimate of feasible volume of business with this account, i.e.: Factual numbers x Chance of Success “You don’t want to spend time and money in a lost case”
  116. Profile and Classify Potential: • Estimate of feasible volume of business with this account, i.e.: Factual numbers x Chance of Success “You don’t want to spend time and money in a lost case” AND
  117. Profile and Classify Quality of Account: Potential: • Estimate of feasible volume of business with this account, i.e.: Factual numbers x Chance of Success “You don’t want to spend time and money in a lost case” AND
  118. Profile and Classify Quality of Account: • Quality of organization & organizational development Potential: • Estimate of feasible volume of business with this account, i.e.: Factual numbers x Chance of Success “You don’t want to spend time and money in a lost case” AND
  119. Profile and Classify Quality of Account: • Quality of organization & organizational development • Quality of care provision and development of care Potential: • Estimate of feasible volume of business with this account, i.e.: Factual numbers x Chance of Success “You don’t want to spend time and money in a lost case” AND
  120. Profile and Classify Quality of Account: • Quality of organization & organizational development • Quality of care provision and development of care • Quality of our relationship with this Account/DMU Potential: • Estimate of feasible volume of business with this account, i.e.: Factual numbers x Chance of Success “You don’t want to spend time and money in a lost case” AND
  121. Segment 1 Segment 2 Segment 3 Segment 4
  122. Segment 1 Segment 2 Segment 3 Segment 4 Differentiate within a new segmentation
  123. Segment 1 Segment 2 Segment 3 Segment 4 Professional & Care Profile Account Differentiate within a new segmentation
  124. Segment 1 Segment 2 Segment 3 Segment 4 Relationship Professional & Care Profile Account Differentiate within a new segmentation
  125. Segment 1 Segment 2 Segment 3 Segment 4Develop Relationship Professional & Care Profile Account Differentiate within a new segmentation
  126. Segment 1 Segment 2 Segment 3 Segment 4Develop Build Relationship Professional & Care Profile Account Differentiate within a new segmentation
  127. Segment 1 Segment 2 Segment 3 Segment 4 Co-create Develop Build Relationship Professional & Care Profile Account Differentiate within a new segmentation
  128. Segment 1 Segment 2 Segment 3 Segment 4 Co-create Partner Develop Build Relationship Professional & Care Profile Account Differentiate within a new segmentation
  129. Segment 1 Segment 2 Segment 3 Segment 4 Co-create Partner Develop Build Relationship Professional & Care Profile Account Differentiate within a new segmentation
  130. Develop your promotion
  131. Develop your promotion Create a path of development From (e)detailing to partnership
  132. Develop your promotion Create a path of development From (e)detailing to partnership
  133. Develop your promotion Create a path of development From (e)detailing to partnership Detail e- Detail Co-CreateCo- Operate
  134. Develop your promotion Create a path of development From (e)detailing to partnership Detail e- Detail Promote & Engage Co-CreateCo- Operate
  135. Develop your promotion Create a path of development From (e)detailing to partnership Detail e- Detail Promote & Engage Connect & Interact Co-CreateCo- Operate
  136. Develop your promotion Create a path of development From (e)detailing to partnership Detail e- Detail Promote & Engage Connect & Interact Develop & Create Co-CreateCo- Operate
  137. Develop your promotion Create a path of development From (e)detailing to partnership Detail e- Detail Promote & Engage Connect & Interact •Inform •Educate Develop & Create Co-Create •Show Co- Operate •Demo
  138. Develop your promotion Create a path of development From (e)detailing to partnership Detail e- Detail Promote & Engage Connect & Interact •Service •Share•Inform •Educate •Collaborate Develop & Create Co-Create •Support•Show Co- Operate •Demo
  139. Develop your promotion Create a path of development From (e)detailing to partnership Detail e- Detail Promote & Engage Connect & Interact •Service •Share•Inform •Educate •Collaborate Develop & Create Co-Create •Support •Co-Evaluate • Create Integrated Patient Care • Create partnerships •Show Co- Operate •Demo
  140. Develop your promotion Detail e- Detail Promote & Engage Connect & Interact Develop & Create Co-Create Co-Operate
  141. Develop your promotion In the course of this roadmap from (e)detailing to partnership you might want to: Detail e- Detail Promote & Engage Connect & Interact Develop & Create Co-Create Co-Operate
  142. Develop your promotion In the course of this roadmap from (e)detailing to partnership you might want to: Detail e- Detail Promote & Engage Connect & Interact Develop & Create Co-Create Co-Operate • Expand physicians’ internal relations with external ones through social media
  143. Develop your promotion In the course of this roadmap from (e)detailing to partnership you might want to: Detail e- Detail Promote & Engage Connect & Interact Develop & Create Co-Create Co-Operate • Expand physicians’ internal relations with external ones through social media • Multi Channel Management Use different channels of communication
  144. Develop your promotion In the course of this roadmap from (e)detailing to partnership you might want to: Detail e- Detail Promote & Engage Connect & Interact Develop & Create Co-Create Co-Operate • Expand physicians’ internal relations with external ones through social media • Multi Channel Management Use different channels of communication • Add mobile
  145. Engage Promote Develop
  146. Profiling DMU’s Segmentation & Targeting DMU Management Development of Partnership Engage Promote Develop
  147. Development of Partnership
  148. 4. Level of Integration 3. Partner Level 1. Level of Transaction 2. Level of Cooperation Development of Partnership
  149. 4. Level of Integration 3. Partner Level 1. Level of Transaction 2. Level of Cooperation Service Offering Sponsoring These are our services Sponsor contract: Utilizing capacity, Experience and“know how”. Development of Partnership
  150. 4. Level of Integration 3. Partner Level 1. Level of Transaction 2. Level of Cooperation Service Offering Sponsoring Commitment on mutual effort Cooperation to realize goals Implementation Contract: Agreement at DMU level, on effort. These are our services Sponsor contract: Utilizing capacity, Experience and“know how”. Development of Partnership
  151. 4. Level of Integration 3. Partner Level 1. Level of Transaction 2. Level of Cooperation Service Offering Sponsoring Commitment on mutual effort Cooperation to realize goals Implementation Contract: Agreement at DMU level, on effort. These are our services Sponsor contract: Utilizing capacity, Experience and“know how”. Development of Partnership
  152. 4. Level of Integration 3. Partner Level 1. Level of Transaction 2. Level of Cooperation Commitment to joint Results Service Offering Sponsoring Commitment on mutual effort Design and realization of tailor made solutions Contract to design and implement Based on customer knowledge, and in co-maker-ship. Cooperation to realize goals Implementation Contract: Agreement at DMU level, on effort. These are our services Sponsor contract: Utilizing capacity, Experience and“know how”. Development of Partnership
  153. 4. Level of Integration 3. Partner Level 1. Level of Transaction 2. Level of Cooperation Multi party deal on Health Outcomes Commitment to joint Results Service Offering Sponsoring Commitment on mutual effort Targeting healthcare outcomes with more stakeholders Contract to integrated care with more parties: outcome directed, long term, In development and improvement. Design and realization of tailor made solutions Contract to design and implement Based on customer knowledge, and in co-maker-ship. Cooperation to realize goals Implementation Contract: Agreement at DMU level, on effort. These are our services Sponsor contract: Utilizing capacity, Experience and“know how”. Development of Partnership
  154. Key Customer Focus Cycle
  155. Key Customer Focus Cycle
  156. Drs.A.R.J. Halkes MHA rob.halkes@healthbusinessconsult.com P.O. Box 292 5050 AG Goirle The Netherlands M +31 6 31 66 2595 T http://www.twitter.com/rohal F http://www.facebook.com/rob.halkes  L http://nl.linkedin.com/in/arjhalkes  W www.healthbusinessconsult.com   
Advertisement